June 11, 2010 (FinancialWire) — Clarient, Inc. (NASDAQ: CLRT), a diagnostic and testing firm serving pathologists, oncologists and the pharmaceutical industry, said it has inked a contractual agreement with Generation Health, Inc. making Clarient a preferred genetic testing lab for GH.

According to Clarient, the deal ensures reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expands Clarient's potential market.

GH is a genetic benefit management company partially-owned by CVS Caremark (NYSE: CVS), the nation's largest pharmacy healthcare provider.

GH and Clarient will begin partnering in July 2010 to facilitate the diagnostic testing for gene mutations in patients who suffer from certain oncology indications. In January 2011, plans are to expand the program, offering managed diagnostic testing to all GH clients.

California-based Clarient combines diagnostic technologies with pathology expertise to assess and characterize cancer.  

Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate, courtesy of Stock Smart (at http://investrend.stocksmart.com/ss/html/hpcompany.html).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

[hlmsmlh] [hlthcrdp] [nwdlsldw] [btnwswntb] [insrncnrs] [prtnrshpsphs]